The CPA will be initiating and engaging in research projects in 2022. If you're interested in a research collaboration, please reach out to us.
There is an evergrowing body of research being conducted by experts and organizations around the world. Listed below are a few of these studies.
One of the powerful potential effects of psilocybin being studied is related to treatment-resistant depression, with 71% of participants reporting antidepressant effects 6 months after the initial psilocybin session. This treatment was combined with professional preparation and integration.
Read more >"Reductions in anxiety, depression, hopelessness, demoralization, and death anxiety" were found in 60-80% of patients with cancer-related distress, suggesting psilocybin could be an effective psychiatric tool for patients with cancer experiencing psychological distress, such as fear of death.
Read more >This study showed that a single dose of psilocybin, in a social setting, can increase creativity, empathy, and wellbeing. These traits are important for social interaction and subjective wellbeing. When these traits are compromised, for example in an individual with depression, psilocybin becomes a potential option.
Read more >Several lines of evidence suggest that classic (5HT2A agonist) hallucinogens have clinically relevant effects in alcohol and drug addiction.
Read more >Researchers at Johns Hopkins University are studying psilocybin — a psychoactive substance found in certain kinds of mushrooms — to see whether it can help people with depression and Alzheimer's Disease when administered in a safe and supportive setting.
Read more >